Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lynde

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2010
Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markersJ Aubert, P Reiniche, P Fogel, et al.
Journal of Critical Care|October 9, 2018
Highly visible sepsis publications from 2012 to 2017: Analysis and comparison of altmetrics and bibliometricsCraig S Jabaley, Robert F Groff, Michael J Stentz, et al.
Anesthesia and Analgesia|December 27, 2018
Chronic Atypical Antipsychotic Use Is Associated With Reduced Need for Postoperative Nausea and Vomiting Rescue in the Postanesthesia Care Unit: A Propensity-Matched Retrospective Observational StudyCraig S Jabaley, Dennis W Gray, Gaurav S Budhrani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 15, 2023
Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trialsE L Simpson, K Rahawi, X Hu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B studyJ I Silverberg, A Pinter, A Alavi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 11, 2014
Effect of biologics on depressive symptoms in patients with psoriasis: a systematic reviewP Fleming, C Roubille, V Richer, et al.
The British Journal of Dermatology|April 16, 2003
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategiesC Ellis, T Luger, D Abeck, et al.
Allergy|May 26, 2017
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSUM Maurer, M Abuzakouk, F Bérard, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Allergy|February 21, 2018
Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSUG Sussman, M Abuzakouk, F Bérard, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2010
Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markersJ Aubert, P Reiniche, P Fogel, et al.
Journal of Critical Care|October 9, 2018
Highly visible sepsis publications from 2012 to 2017: Analysis and comparison of altmetrics and bibliometricsCraig S Jabaley, Robert F Groff, Michael J Stentz, et al.
Anesthesia and Analgesia|December 27, 2018
Chronic Atypical Antipsychotic Use Is Associated With Reduced Need for Postoperative Nausea and Vomiting Rescue in the Postanesthesia Care Unit: A Propensity-Matched Retrospective Observational StudyCraig S Jabaley, Dennis W Gray, Gaurav S Budhrani, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 15, 2023
Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: Results from two randomized phase 3 trialsE L Simpson, K Rahawi, X Hu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 12, 2021
Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B studyJ I Silverberg, A Pinter, A Alavi, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 11, 2014
Effect of biologics on depressive symptoms in patients with psoriasis: a systematic reviewP Fleming, C Roubille, V Richer, et al.
The British Journal of Dermatology|April 16, 2003
International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategiesC Ellis, T Luger, D Abeck, et al.
Allergy|May 26, 2017
The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSUM Maurer, M Abuzakouk, F Bérard, et al.
The British Journal of Dermatology|October 1, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2)A Wollenberg, A Blauvelt, E Guttman-Yassky, et al.
Allergy|February 21, 2018
Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSUG Sussman, M Abuzakouk, F Bérard, et al.
Pageof 6